Previous 10 | Next 10 |
home / stock / dgnof / dgnof news
BROSSARD, Quebec, Feb. 10, 2023 (GLOBE NEWSWIRE) -- February 10, 2023 – Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FL AI RE platform based...
BROSSARD, Quebec, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform based ...
BROSSARD, Quebec, Dec. 15, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FL AI RE platform based on Artificial Intelligence ( ...
BROSSARD, Quebec, Oct. 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform ...
BROSSARD, Quebec, Aug. 18, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform ...
BROSSARD, Quebec, July 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform ...
BROSSARD, Quebec, June 23, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform ...
BROSSARD, Quebec, June 07, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform ...
BROSSARD, Quebec, May 26, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform b...
BROSSARD, Quebec, May 10, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform b...
News, Short Squeeze, Breakout and More Instantly...
BROSSARD, Quebec, May 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its FL AI RE platform based on Artificial Intelligence ( AI ), is ...
BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, in collaboration with ETS, École de Technologie ...
BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new H...